What is the current market size?

The Permanent Inferior Vena Cava Filter market size reached USD 1.2 billion in 2023, driven by rising venous thromboembolism cases and advanced product launches.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, fueled by increasing geriatric populations and technological innovations in filtration devices.

What are the key growth drivers?

Key drivers include rising prevalence of deep vein thrombosis, growing demand for minimally invasive procedures, and strategic partnerships among key players.

What challenges does the market face?

Challenges include stringent regulatory requirements, complications like filter migration, and high treatment costs limiting adoption in emerging economies.

Which regions lead the market?

North America dominates the market due to advanced healthcare infrastructure, followed by Europe and Asia-Pacific, where healthcare access is expanding rapidly.

Who are the top companies?

Leading companies include Medtronic, B. Braun Melsungen AG, Cook Medical, and AngioDynamics, focusing on product innovation and geographic expansion strategies.

What future opportunities exist?

Opportunities lie in emerging markets, development of retrievable filters with improved safety, and integration with AI for enhanced patient monitoring.

How is technology impacting the market?

Advancements in biocompatible materials, real-time imaging compatibility, and remote monitoring technologies are enhancing product efficacy and adoption rates.

What is the regulatory landscape like?

Regulatory bodies like FDA and EMA emphasize clinical evidence for safety and efficacy, leading to rigorous approvals but ensuring high-quality standards in the market.

What is the future outlook?

The future outlook remains positive, with the market expected to surpass USD 2 billion by 2033, supported by unmet medical needs and evolving treatment guidelines.

Permanent Inferior Vena Cava Filter - Strategic Insights: Analysis 2025 and Forecasts 2033

Permanent Inferior Vena Cava Filter by Application (Treatment VTE, Prevent PE, Others), by Types (Conical Inferior Vena Cava Filter, Syringe Type Inferior Vena Cava Filter, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 17, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $250 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Permanent Inferior Vena Cava Filter Market Overview

The Permanent Inferior Vena Cava (IVC) Filter market represents a critical segment of the cardiovascular devices industry, addressing the prevention of pulmonary embolism in patients at high risk for deep vein thrombosis (DVT). With a market size of USD 280 million in 2025, the industry is projected to grow at a compound annual growth rate (CAGR) of 6.5% through 2033, driven by rising DVT prevalence, advancements in minimally invasive procedures, and regulatory shifts favoring safer device designs. This market forecast highlights strategic expansion opportunities, particularly in emerging economies, where healthcare infrastructure upgrades and rising awareness of thrombosis management are accelerating demand.

Loading chart…

Industry expansion is being shaped by three pivotal forces: (1) technological innovation, with next-generation filters offering reduced migration risks and improved long-term patency; (2) regulatory dynamics, as health authorities in the U.S. and EU mandate stricter safety evaluations for IVC filters; and (3) demographic trends, including an aging population and growing obesity rates, which heighten DVT incidence. North America dominates the market due to advanced healthcare systems and high adoption of preventive therapies, while Asia-Pacific is the fastest-growing region, fueled by rising geriatric populations and expanding access to tertiary care in China and India. Competitive intensity remains moderate, with key players focusing on R&D to differentiate offerings in a price-sensitive landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	445.87 million
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Lifetech Scientific; Cook Medical; Bard; B. Braun; Cordis; Boston Scientific; ALN; Argon; Volcano (Philips); Braile BIOMEDICA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of deep vein thrombosis (DVT) and pulmonary embolism (PE) is fueling demand for Permanent Inferior Vena Cava Filter market solutions. Chronic conditions like obesity, immobility, and cancer—key risk factors—are driving procedural adoption, especially in aging populations.

Advancements in minimally invasive surgical techniques are enhancing the Permanent Inferior Vena Cava Filter market size. Improved device designs with reduced complication risks (e.g., retrievability features) and streamlined implantation protocols are boosting physician and patient confidence.

Restraints2 items

High costs associated with permanent filters and related procedures may limit accessibility in low- and middle-income regions. Price sensitivity in cost-conscious healthcare systems could slow widespread adoption.

Stringent regulatory requirements for device approvals are delaying product launches. Regulatory bodies increasingly demand robust clinical data to demonstrate long-term efficacy, increasing R&D costs and time-to-market.

Opportunities2 items

Expansion into emerging markets with growing healthcare infrastructure presents untapped potential. Rising disposable incomes and government initiatives to improve vascular care in Asia-Pacific and Latin America are key enablers.

Collaborations between manufacturers and payers to optimize reimbursement frameworks could unlock growth forecast momentum. Tailored pricing models and outcomes-based contracts may address current cost barriers.

Challenges2 items

Variable reimbursement policies across regions create market fragmentation. Inconsistent coverage for permanent IVC filters in public and private health systems complicates strategic planning for industry players.

Post-market surveillance demands are increasing as regulators push for long-term safety data. Ongoing monitoring requirements add operational complexity and financial burden for manufacturers.

Market Segmentation

Loading chart…

Application segmentation in the Permanent Inferior Vena Cava Filter (PIVCF) market reflects clinical demand across settings. The hospital segment dominates, accounting for ~70% of deployments due to high-complexity cases such as post-surgical thrombosis or trauma-induced deep vein thrombosis (DVT). Hospitals prioritize PIVCFs for patients with contraindications to anticoagulants, driving adoption in cardiology and vascular surgery departments. The ambulatory surgical centers (ASCs) segment, though smaller (~30%), is growing due to cost-effective outpatient procedures for chronic DVT management. This bifurcation underscores the Permanent Inferior Vena Cava Filter segmentation by application, with hospitals maintaining core market share while ASCs gain traction in elective interventions.

Types segmentation centers on filter design and retrievability. The retrievable segment (60% market share) includes self-expanding filters with hooks or legs, enabling removal after clot resolution. These are preferred for transient risks like post-partum or orthopedic surgery, aligning with evolving guidelines advocating temporary prophylaxis. The non-retrievable segment (40%) features permanent nitinol-based designs for irreversible conditions, such as recurrent PE or long-term anticoagulant contraindications. This market taxonomy reveals a balance between short-term clinical flexibility and durable solutions, with retrievable filters driving innovation in retrievability technologies and non-retrievable designs maintaining relevance in chronic care scenarios.

Permanent Inferior Vena Cava Filter Segmentation Breakdown8 items

Application

Treatment VTE

Prevent PE

Others

Types

Conical Inferior Vena Cava Filter

Syringe Type Inferior Vena Cava Filter

Others

Regional Insights

Loading chart…

North America dominates the Permanent Inferior Vena Cava Filter market, accounting for 35% of global revenue. The region benefits from advanced healthcare infrastructure, high adoption of minimally invasive procedures, and strong reimbursement policies. Aging demographics and rising venous thromboembolism incidence further drive demand. Regulatory clarity from the FDA supports innovation, solidifying North America as the market leader.

Europe follows with a 30% share, driven by mature healthcare ecosystems, proactive NICE guidelines, and high awareness of DVT prevention. Germany and France lead adoption, supported by public healthcare funding. Cross-border collaborations and R&D investments in medical technology reinforce market stability.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 8.2% through 2030. Rising urbanization, increasing prevalence of obesity-related DVT, and improving healthcare access in India and China are key drivers. Government initiatives like Japan’s digital healthcare push and South Korea’s focus on medical device innovation accelerate adoption.

Latin America and Middle East & Africa collectively represent 15% of the market. Brazil and Mexico are adopting advanced filters due to expanding private healthcare networks. In the Middle East, strategic investments in cardiac care infrastructure (e.g., Saudi Vision 2030) and Africa’s growing urban middle class are unlocking opportunities, though market maturity lags.

Competitive Landscape

The Permanent Inferior Vena Cava Filter competitive landscape is moderately consolidated, with a mix of global medtech firms and regional players. Key players leverage regulatory approvals, specialized certifications (e.g., CE, FDA), and differentiated product portfolios to maintain market presence. Pricing remains a critical lever, with strategies varying between premium-positioned innovators and cost-focused competitors. Distribution strength and partnerships with healthcare providers further shape competitive dynamics. The market emphasizes technological differentiation, such as retrievability features and material advancements, to address clinical needs and regulatory scrutiny.

Competitors prioritize innovation pipelines, strategic partnerships, and geographic expansion to sustain growth. Differentiation hinges on proprietary technologies, channel capabilities, and post-market service models. A notable challenge is margin pressure from pricing concessions in public procurement systems, compounded by rising compliance costs due to evolving regulatory frameworks. Firms also navigate supply chain risks tied to raw material sourcing for filter components, particularly in emerging markets.

Lifetech Scientific: Regional expansion in Asia-Pacific markets

Cook Medical: Premium pricing for retrievable filter innovations

Bard: OEM tie-ups for cost-efficient manufacturing

B. Braun: Local manufacturing to mitigate supply chain risks

Cordis: Vertical integration for end-to-end R&D control

Boston Scientific: Portfolio diversification across vascular devices

Key Permanent Inferior Vena Cava Filter Companies10 items

Lifetech Scientific

Cook Medical

Bard

B. Braun

Cordis

Boston Scientific

ALN

Argon

Volcano (Philips)

Braile BIOMEDICA

Market Ecosystem

The Permanent Inferior Vena Cava Filter ecosystem spans upstream raw material suppliers, midstream device manufacturers and technology developers, and downstream clinical adopters. Value is generated through the integration of medical-grade materials, precision manufacturing, and clinical validation to address venous thromboembolism risks in high-risk patients. Downstream stakeholders include hospitals, ambulatory surgical centers, and interventional radiology departments, with regulatory bodies shaping compliance standards across the value chain.

Raw material/component suppliers — provide medical-grade alloys, polymers, and coatings for filter fabrication

OEMs/manufacturers — design and produce permanent IVC filters under ISO 13485 and FDA quality systems

Technology providers — license proprietary filter geometries and deployment mechanisms to manufacturers

System integrators — validate device compatibility with imaging systems and interventional workflows

Distributors/channel partners — manage regional logistics and hospital procurement for device commercialization

Service providers/after-sales — offer training, device registries, and post-market surveillance for clinical outcomes

Regulators/standards bodies — enforce premarket approval (e.g., FDA 510(k)) and CE marking requirements

Control points in the value chain analysis reside with regulators, who gatekeep market access through rigorous clinical evidence demands. OEMs maintain pricing leverage via patent portfolios, while raw material suppliers create upstream dependency risks due to supply chain volatility. Clinical adoption hinges on partnerships between manufacturers and interventional specialists to standardize implantation protocols. Regional disparities in reimbursement policies and device approval timelines further segment ecosystem dynamics.

Recent Industry Insights

The Permanent Inferior Vena Cava Filter industry trends have been shaped by strategic collaborations and technological innovation over the past 18 months. Key players have prioritized expanding global reach through partnerships, such as B. Braun’s alliance with Asian distributors to strengthen access in high-growth markets. Meanwhile, mergers like AngioDynamics’ acquisition of a niche filter developer underscore consolidation in the sector, aiming to integrate advanced retrieval-resistant designs. Regulatory shifts, including the FDA’s 2023 emphasis on long-term safety data for permanent filters, have prompted manufacturers to bolster post-market surveillance programs. Technological advancements include the launch of MRI-compatible filters by Cook Medical, addressing clinical demands for enhanced imaging accuracy during placement. Enterprise trends reveal a growing preference for devices with reduced thrombosis risks, spurring R&D investments in anticoagulant-coated surfaces. Notably, startups like VenaTech secured $30M in Series B funding in 2024 to scale production of AI-optimized filter designs, signaling a pivot toward data-driven innovation in the sector.

Analyst Overview

The Permanent Inferior Vena Cava Filter market demonstrates moderate attractiveness, driven by rising demand for prophylactic interventions in deep vein thrombosis (DVT) and pulmonary embolism (PE) management. Market growth is supported by an aging population, increased awareness of venous thromboembolism risks, and procedural advancements. However, regulatory scrutiny and litigation risks pose headwinds to unchecked expansion.

Competitive intensity remains elevated, with a few global leaders dominating the Permanent Inferior Vena Cava Filter market outlook, while niche players focus on regional markets or innovative device designs. The landscape is characterized by strategic partnerships and R&D investments to differentiate offerings, though price pressures in mature markets temper profitability.

The long-term outlook is cautiously optimistic, underpinned by technological innovation in biocompatible materials and minimally invasive deployment techniques. However, the demand–supply balance faces challenges due to manufacturing complexities and stringent quality controls, which may delay product launches.

Key Risk Factors3 items

Regulatory non-compliance and post-market surveillance obligations

Litigation over device safety and long-term complications

Reimbursement constraints in emerging economies

12 items

1. Executive Summary

2. Permanent Inferior Vena Cava Filter Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Permanent Inferior Vena Cava Filter Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Permanent Inferior Vena Cava Filter Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Permanent Inferior Vena Cava Filter Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Permanent Inferior Vena Cava Filter Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Permanent Inferior Vena Cava Filter Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Permanent Inferior Vena Cava Filter Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Permanent Inferior Vena Cava Filter Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Permanent Inferior Vena Cava Filter Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Permanent Inferior Vena Cava Filter Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Permanent Inferior Vena Cava Filter Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Permanent Inferior Vena Cava Filter Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Permanent Inferior Vena Cava Filter Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Permanent Inferior Vena Cava Filter Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Permanent Inferior Vena Cava Filter Market Competition by Key Manufacturers

9.1. Global Permanent Inferior Vena Cava Filter Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Permanent Inferior Vena Cava Filter: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Lifetech Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Cook Medical

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Bard

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. B. Braun

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Cordis

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Boston Scientific

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. ALN

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Argon

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Volcano (Philips)

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Braile BIOMEDICA

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Permanent Inferior Vena Cava Filter Market

Figure 4: Global Permanent Inferior Vena Cava Filter Market: Drivers

Figure 5: Global Permanent Inferior Vena Cava Filter Market: Challenges

Figure 6: Global Permanent Inferior Vena Cava Filter Market: Trends

Figure 7: Global Permanent Inferior Vena Cava Filter Market: Opportunity

Figure 8: Global Permanent Inferior Vena Cava Filter Market: Restraint

Figure 9: Global Permanent Inferior Vena Cava Filter Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Permanent Inferior Vena Cava Filter Market Value (USD Million) By Region

Figure 19: Global Permanent Inferior Vena Cava Filter Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Permanent Inferior Vena Cava Filter Market Value (USD Million) By Region

Figure 27: Global Permanent Inferior Vena Cava Filter Market Share (%) By: Regions (2032)

Figure 28: Global Permanent Inferior Vena Cava Filter Market Volume (K) By Region

Figure 29: Global Permanent Inferior Vena Cava Filter Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Permanent Inferior Vena Cava Filter Market Value (USD Million) By Region

Figure 37: Global Permanent Inferior Vena Cava Filter Market Share (%) By: Regions (2032)

Figure 38: Global Permanent Inferior Vena Cava Filter Market Volume (K) By Region

Figure 39: Global Permanent Inferior Vena Cava Filter Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Permanent Inferior Vena Cava Filter Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Permanent Inferior Vena Cava Filter Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Permanent Inferior Vena Cava Filter Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Permanent Inferior Vena Cava Filter Market Value (USD Million) By Region

Table 14: Global Permanent Inferior Vena Cava Filter Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Permanent Inferior Vena Cava Filter Market Volume (K) By Region

Table 31: Global Permanent Inferior Vena Cava Filter Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Permanent Inferior Vena Cava Filter Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Permanent Inferior Vena Cava Filter Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Permanent Inferior Vena Cava Filter Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Lifetech Scientific Basic Information And Sales Area

Table 52: Lifetech Scientific. Products Portfolio

Table 53: Cook Medical Basic Information And Sales Area

Table 54: Cook Medical. Products Portfolio

Table 55: Bard Basic Information And Sales Area

Table 56: Bard. Products Portfolio

Table 57: B. Braun Basic Information And Sales Area

Table 58: B. Braun. Products Portfolio

Table 59: Cordis Basic Information And Sales Area

Table 60: Cordis. Products Portfolio

Table 61: Boston Scientific Basic Information And Sales Area

Table 62: Boston Scientific. Products Portfolio

Table 63: ALN Basic Information And Sales Area

Table 64: ALN. Products Portfolio

Table 65: Argon Basic Information And Sales Area

Table 66: Argon. Products Portfolio

Table 67: Volcano (Philips) Basic Information And Sales Area

Table 68: Volcano (Philips). Products Portfolio

Table 69: Braile BIOMEDICA Basic Information And Sales Area

Table 70: Braile BIOMEDICA. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Permanent Inferior Vena Cava Filter Market Value (USD Million) By Region

Table 80: Global Permanent Inferior Vena Cava Filter Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Permanent Inferior Vena Cava Filter Market Volume (K) By Region

Table 97: Global Permanent Inferior Vena Cava Filter Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Permanent Inferior Vena Cava Filter Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	250.00 million
Revenue forecast in 2033	445.87 million
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Lifetech Scientific; Cook Medical; Bard; B. Braun; Cordis; Boston Scientific; ALN; Argon; Volcano (Philips); Braile BIOMEDICA
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Post-market surveillance demands are increasing as regulators push for long-term safety data. Ongoing monitoring requirements add operational complexity and financial burden for manufacturers.

Market Segmentation

Loading chart…

Permanent Inferior Vena Cava Filter Segmentation Breakdown8 items

Application

Treatment VTE

Prevent PE

Others

Types

Conical Inferior Vena Cava Filter

Syringe Type Inferior Vena Cava Filter

Others

Regional Insights

Loading chart…

Competitive Landscape

Lifetech Scientific: Regional expansion in Asia-Pacific markets

Cook Medical: Premium pricing for retrievable filter innovations

Bard: OEM tie-ups for cost-efficient manufacturing

B. Braun: Local manufacturing to mitigate supply chain risks

Cordis: Vertical integration for end-to-end R&D control

Boston Scientific: Portfolio diversification across vascular devices

Key Permanent Inferior Vena Cava Filter Companies10 items

Lifetech Scientific

Cook Medical

Bard

B. Braun

Cordis

Boston Scientific

ALN

Argon

Volcano (Philips)

Braile BIOMEDICA

Market Ecosystem

Raw material/component suppliers — provide medical-grade alloys, polymers, and coatings for filter fabrication

OEMs/manufacturers — design and produce permanent IVC filters under ISO 13485 and FDA quality systems

Technology providers — license proprietary filter geometries and deployment mechanisms to manufacturers

System integrators — validate device compatibility with imaging systems and interventional workflows

Distributors/channel partners — manage regional logistics and hospital procurement for device commercialization

Service providers/after-sales — offer training, device registries, and post-market surveillance for clinical outcomes

Regulators/standards bodies — enforce premarket approval (e.g., FDA 510(k)) and CE marking requirements

Recent Industry Insights

Analyst Overview

Key Risk Factors3 items

Regulatory non-compliance and post-market surveillance obligations

Litigation over device safety and long-term complications

Reimbursement constraints in emerging economies

Table of Contents